Compile Data Set for Download or QSAR
Report error Found 76 Enz. Inhib. hit(s) with all data for entry = 2045
LigandPNGBDBM16384(4-(4-fluorophenyl)-5-[3-(2-methoxyphenyl)-[1,2,4]t...)
Affinity DataIC50: 0.400nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16385(5-[3-(2-ethoxyphenyl)-[1,2,4]triazolo[3,4-a]pyridi...)
Affinity DataIC50: 0.400nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16390(4-(2,4-difluorophenyl)-5-[3-(1-methylcyclopropyl)-...)
Affinity DataIC50: 0.700nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16393(5-{3-tert-butyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl...)
Affinity DataIC50: 1.10nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16392(4-(2,4-difluorophenyl)-5-[3-(1-methylcyclobutyl)-[...)
Affinity DataIC50: 1.10nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16398(4-(2,5-difluorophenyl)-5-[3-(1-methylcyclobutyl)-[...)
Affinity DataIC50: 1.5nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16404(5-{3-tert-butyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl...)
Affinity DataIC50: 1.80nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16346(4-(4-chloro-2-fluorophenyl)-5-[3-(propan-2-yl)-[1,...)
Affinity DataIC50: 2.20nMpH: 7.2 T: 2°CAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16401(5-[3-(1-methylcyclopropyl)-[1,2,4]triazolo[3,4-a]p...)
Affinity DataIC50: 2.30nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16403(5-[3-(1-methylcyclobutyl)-[1,2,4]triazolo[3,4-a]py...)
Affinity DataIC50: 2.5nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16348(4-(2-chloro-4-fluorophenyl)-5-[3-(propan-2-yl)-[1,...)
Affinity DataIC50: 2.5nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16405(3-(2,5-difluorophenyl)-4-[3-(propan-2-yl)-[1,2,4]t...)
Affinity DataIC50: 2.80nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16340(4-(2-chlorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triaz...)
Affinity DataIC50: 3nMpH: 7.2 T: 2°CAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16396(4-(2,5-difluorophenyl)-5-[3-(1-methylcyclopropyl)-...)
Affinity DataIC50: 3nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16351(5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6...)
Affinity DataIC50: 3.20nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16389(5-{3-cyclopropyl-[1,2,4]triazolo[3,4-a]pyridin-6-y...)
Affinity DataIC50: 3.5nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16386(5-{3-tert-butyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl...)
Affinity DataIC50: 3.5nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16391(5-{3-cyclobutyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl...)
Affinity DataIC50: 3.75nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16350(5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6...)
Affinity DataIC50: 4.10nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16337(4-(2-fluoro-5-methylphenyl)-5-[3-(propan-2-yl)-[1,...)
Affinity DataIC50: 4.30nMpH: 7.2 T: 2°CAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16341(4-(2,4-difluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]t...)
Affinity DataIC50: 4.60nMpH: 7.2 T: 2°CAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16379(N-ethyl-6-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]-N-m...)
Affinity DataIC50: 4.70nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM15414(6-[4-(4-Fluoro-phenyl)-oxazol-5-yl]-3-isopropyl-[1...)
Affinity DataIC50: 5nMpH: 7.2 T: 2°CAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16347(4-(5-chloro-2-fluorophenyl)-5-[3-(propan-2-yl)-[1,...)
Affinity DataIC50: 5.10nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16364(N-ethyl-6-(4-phenyl-1,3-oxazol-5-yl)-[1,2,4]triazo...)
Affinity DataIC50: 5.40nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16377(6-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]-N-(propan-2...)
Affinity DataIC50: 5.5nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16359(4-(2-chloro-4,5-difluorophenyl)-5-[3-(propan-2-yl)...)
Affinity DataIC50: 5.60nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16342(4-(2,5-difluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]t...)
Affinity DataIC50: 5.80nMpH: 7.2 T: 2°CAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16407(4-(2,5-difluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]t...)
Affinity DataIC50: 6.20nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16336(4-(4-fluoro-3-methylphenyl)-5-[3-(propan-2-yl)-[1,...)
Affinity DataIC50: 6.60nMpH: 7.2 T: 2°CAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16352(5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6...)
Affinity DataIC50: 7.20nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16372(N-ethyl-6-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]-[1,...)
Affinity DataIC50: 7.60nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16400(5-{3-cyclopropyl-[1,2,4]triazolo[3,4-a]pyridin-6-y...)
Affinity DataIC50: 7.80nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16360(4-(3-bromo-4-fluorophenyl)-5-[3-(propan-2-yl)-[1,2...)
Affinity DataIC50: 8nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16356(4-(2,4-dichlorophenyl)-5-[3-(propan-2-yl)-[1,2,4]t...)
Affinity DataIC50: 8.30nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16399(5-{3-tert-butyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl...)
Affinity DataIC50: 8.80nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16376(4-(4-fluorophenyl)-5-[3-(2-methylpropyl)-[1,2,4]tr...)
Affinity DataIC50: 8.80nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16402(5-{3-cyclobutyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl...)
Affinity DataIC50: 9.10nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16365(N-ethyl-N-methyl-6-(4-phenyl-1,3-oxazol-5-yl)-[1,2...)
Affinity DataIC50: 9.20nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16333(4-phenyl-5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]...)
Affinity DataIC50: 9.60nMpH: 7.2 T: 2°CAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16397(5-{3-cyclobutyl-[1,2,4]triazolo[3,4-a]pyridin-6-yl...)
Affinity DataIC50: 9.70nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16375(5-{3-cyclopropyl-[1,2,4]triazolo[3,4-a]pyridin-6-y...)
Affinity DataIC50: 10.9nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16354(5-[3-(propan-2-yl)-[1,2,4]triazolo[3,4-a]pyridin-6...)
Affinity DataIC50: 11.1nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16387(4-{6-[4-(4-fluorophenyl)-1,3-oxazol-5-yl]-[1,2,4]t...)
Affinity DataIC50: 11.8nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16383(4-(4-fluorophenyl)-5-{3-phenyl-[1,2,4]triazolo[3,4...)
Affinity DataIC50: 12.3nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16345(4-(3-chloro-4-fluorophenyl)-5-[3-(propan-2-yl)-[1,...)
Affinity DataIC50: 12.4nMpH: 7.2 T: 2°CAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16339(4-(3-chlorophenyl)-5-[3-(propan-2-yl)-[1,2,4]triaz...)
Affinity DataIC50: 13.5nMpH: 7.2 T: 2°CAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16381(4-(4-fluorophenyl)-5-[3-(1-methylcyclobutyl)-[1,2,...)
Affinity DataIC50: 14nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16357(4-(2,3-dichlorophenyl)-5-[3-(propan-2-yl)-[1,2,4]t...)
Affinity DataIC50: 14.5nMAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
LigandPNGBDBM16343(4-(2,6-difluorophenyl)-5-[3-(propan-2-yl)-[1,2,4]t...)
Affinity DataIC50: 14.6nMpH: 7.2 T: 2°CAssay Description:The IC50s were determined by incubating each test compound with activated p38-alpha in a 96-well plate that had been pre-treated with ATF-2-GST to al...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/2/2007
Entry Details Article
PubMed
Displayed 1 to 50 (of 76 total ) | Next | Last >>
Jump to: